[VRDN] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
13-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 11.92%
YoY- -38.12%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 105 1,195 256 216 214 208 1,090 -78.89%
PBT -45,785 -28,905 -29,491 -25,693 -28,946 -14,043 -17,964 86.26%
Tax -3,281 -880 227 -196 3 91 9 -
NP -42,504 -28,025 -29,491 -25,497 -28,946 -14,043 -17,964 77.28%
Tax Rate - - - - - - - -
Total Cost 42,609 29,220 29,747 25,713 29,160 14,251 19,054 70.75%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -40,480.00 -2,345.19 -11,519.92 -11,804.17 -13,526.17 -6,751.44 -1,648.07 740.06%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -1.05 -0.83 -1.06 -0.98 -2.59 -1.26 -2.22 -39.21%
EPS Diluted -1.05 -0.83 -1.06 -0.98 -2.59 -1.26 -2.22 -39.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.